|
1) The Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature. 2007; 447: 661-78
|
|
|
|
2) Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007; 445: 881-5
|
|
|
|
|
|
3) Zeggini E, Weedon MN, Lindgren CM, et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007; 316: 1336-41
|
|
|
|
|
|
4) Scott L J, Mohlke KL, Bonnycastle LL et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007; 316: 1341-5
|
|
|
|
|
|
5) Miyake K, Horikawa Y, Hara K, et al. Association of TCF7L2 polymorphisms with susceptibility to type 2 diabetes in 4, 087 Japanese subjects. J Hum Genet. 2008; 53: 174-80
|
|
|
|
|
6) Horikawa Y, Miyake K, Yasuda K, et al. Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J Clin Endocrinol Metab. 2008; 93: 3136-41
|
|
|
|
|
|
7) Yasuda K, Miyake K, Horikawa Y, et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet. 2008; 40: 1092-7
|
|
|
|
|
|
8) Miyake K, Yang W, Hara K, et al. Construction of a prediction model for type 2 diabetes mellitus in the Japanese population based on 11 genes with strong evidence of the association. J Hum Genet. 2009; 54: 236-41
|
|
|
|
|
|
9) Meigs JB, Shrader P, Sullivan LM, et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med. 2008; 359: 2208-19
|
|
|
|
|
|
10) Lyssenko V, Jonsson A, Almgren P, et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med. 2008; 359: 2220-32
|
|
|
|
|
|
11) Unoki H, Takahashi A, Kawaguchi T, et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet. 2008; 40: 1098-102
|
|
|
|
|
|
12) Müssig K, Staiger H, Machicao F, et al. Association of type 2 diabetes candidate polymorphisms in KCNQ1 with incretin and insulin secretion. Diabetes. 2009; 58: 1715-20
|
|
|
|
|
|
13) Boini KM, Graf D, Hennige AM, et al. Enhanced insulin sensitivity of gene-targeted mice lacking functional KCNQ1. Am J Physiol Regul Integr Comp Physiol. 2009; 296: R1695-701
|
|
|
|
|
|
14) Du M, Beatty LG, Zhou W, et al. Insulator and silencer sequences in the imprinted region of human chromosome 11p15. 5. Hum Mol Genet. 2003; 12: 1927-39
|
|
|
|
|
|
15) Kong A, Steinthorsdottir V, Masson G, et al. Parental origin of sequence variants associated with complex diseases. Nature. 2009; 462: 868-74
|
|
|
|
|
|
16) Korinek V, Barker N, Moerer P, et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet. 1998; 19: 379-83
|
|
|
|
|
|
17) Fujino T, Asaba H, Kang MJ, et al. Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proc Natl Acad Sci U S A. 2003; 100: 229-34
|
|
|
|
|
|
18) Florez JC, Jablonski KA, Bayley N, et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med. 2006; 355: 241-50
|
|
|
|
|
|
19) Pearson ER, Donnelly LA, Kimber C, et al. Variation in TCF7L2 influences therapeutic response to sulfonylureas, A GoDARTs study. Diabetes. 2007; 56: 2178-82
|
|
|
|
|
|
20) Pilgaard K, Jensen CB, Schou JH, et al. The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men. Diabetologia. 2009; 52: 1298-307
|
|
|
|
|
|
21) Shu L, Matveyenko AV, Kerr-Conte J, et al. Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Hum Mol Genet. 2009; 18: 2388-99
|
|
|
|
|
|
22) Pawitan Y, Seng KC, Magnusson PKE. How many genetic variants remain to be discovered ？ PLoS One. 2009; 4: e7969
|
|
|
|
|
|
23) Gloyn AI, McCarthy MI. Variation across the allele frequency spectrum. Nat Genet 2010; 42: 648-50
|
|
|
|
|
|
24) Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010; 42: 579-89
|
|
|
|
|
|
25) Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010; 42: 105-16
|
|
|
|
|
|
26) Poulsen P, Kyvik KO, Tung YC, et al. Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance-a population-based twin study. Diabetologia. 1999; 42: 139-45
|
|
|
|
|
|
27) Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci U S A. 2007; 104: 13056-61
|
|
|
|
|
|
28) Rassoulzadegan M, Grandjean V, Gounon P, et al. RNA-mediated non-mendelian inheritance of an epigenetic change in the mouse. Nature. 2006; 441: 469-74
|
|
|
|
|
|
29) Jin L, Wang H, Narita T, et al. Expression profile of mRNAs from human pancreatic islet tumors. J Mol Endocrinol. 2003; 31: 519-28
|
|
|
|
|
|
30) Wang H, Horikawa Y, Jin L, et al. Gene expression profile in rat pancreatic islet and RINm5F cells. J Mol Endocrinol. 2005; 35: 1-12
|
|
|
|
|
|
31) Estécio MR, Issa JP. Tackling the methylome: recent methodological advances in genome-wide methylation profiling. Genome Med. 2009; 1: 106-12
|
|
|
|
|